<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Swamynathan MM</submitter><funding>NCI NIH HHS</funding><pagination>eadk9167</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11975464</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>386(6720)</volume><pubmed_abstract>Men taking antioxidant vitamin E supplements have increased prostate cancer (PC) risk. However, whether pro-oxidants protect from PC remained unclear. In this work, we show that a pro-oxidant vitamin K precursor [menadione sodium bisulfite (MSB)] suppresses PC progression in mice, killing cells through an oxidative cell death: MSB antagonizes the essential class III phosphatidylinositol (PI) 3-kinase VPS34-the regulator of endosome identity and sorting-through oxidation of key cysteines, pointing to a redox checkpoint in sorting. Testing MSB in a myotubular myopathy model that is driven by loss of &lt;i>MTM1&lt;/i>-the phosphatase antagonist of VPS34-we show that dietary MSB improved muscle histology and function and extended life span. These findings enhance our understanding of pro-oxidant sel</pubmed_abstract><journal>Science (New York, N.Y.)</journal><pubmed_title>Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function.</pubmed_title><pmcid>PMC11975464</pmcid><funding_grant_id>R01 CA193256</funding_grant_id><funding_grant_id>P30 CA045508</funding_grant_id><funding_grant_id>R01 CA275128</funding_grant_id><funding_grant_id>R01 CA188134</funding_grant_id><funding_grant_id>R01 CA190092</funding_grant_id><funding_grant_id>U01 CA210240</funding_grant_id><funding_grant_id>R01 CA229699</funding_grant_id><funding_grant_id>R01 CA137050</funding_grant_id><funding_grant_id>U01 CA224013</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Minicozzi F</pubmed_authors><pubmed_authors>Spokaite S</pubmed_authors><pubmed_authors>Chakrabarty RP</pubmed_authors><pubmed_authors>Hicks JB</pubmed_authors><pubmed_authors>Chandel NS</pubmed_authors><pubmed_authors>Swamynathan MM</pubmed_authors><pubmed_authors>Kim ST</pubmed_authors><pubmed_authors>Egeblad M</pubmed_authors><pubmed_authors>Wilkinson JE</pubmed_authors><pubmed_authors>Gineste C</pubmed_authors><pubmed_authors>Nowak DG</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors><pubmed_authors>Rivera K</pubmed_authors><pubmed_authors>Tuveson DA</pubmed_authors><pubmed_authors>Trotman LC</pubmed_authors><pubmed_authors>Mathew G</pubmed_authors><pubmed_authors>Park Y</pubmed_authors><pubmed_authors>Diermeier SD</pubmed_authors><pubmed_authors>Cifani P</pubmed_authors><pubmed_authors>Almeida AS</pubmed_authors><pubmed_authors>Dessus AN</pubmed_authors><pubmed_authors>Alsudani H</pubmed_authors><pubmed_authors>Cheng E</pubmed_authors><pubmed_authors>Ghosh D</pubmed_authors><pubmed_authors>Chang K</pubmed_authors><pubmed_authors>Kendall J</pubmed_authors><pubmed_authors>Reczek CR</pubmed_authors><pubmed_authors>Kuang S</pubmed_authors><pubmed_authors>Gong GQ</pubmed_authors><pubmed_authors>Janowitz T</pubmed_authors><pubmed_authors>Wigler M</pubmed_authors><pubmed_authors>Reiss D</pubmed_authors><pubmed_authors>Gimotty PA</pubmed_authors><pubmed_authors>Watrud KE</pubmed_authors><pubmed_authors>Cox H</pubmed_authors><pubmed_authors>Wee TL</pubmed_authors><pubmed_authors>Herzka T</pubmed_authors><pubmed_authors>Williams RL</pubmed_authors><pubmed_authors>Doherty MR</pubmed_authors><pubmed_authors>Pappin DJ</pubmed_authors><pubmed_authors>Klingbeil O</pubmed_authors><pubmed_authors>Vakoc CR</pubmed_authors><pubmed_authors>Laporte J</pubmed_authors><pubmed_authors>Locasale JW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function.</name><description>Men taking antioxidant vitamin E supplements have increased prostate cancer (PC) risk. However, whether pro-oxidants protect from PC remained unclear. In this work, we show that a pro-oxidant vitamin K precursor [menadione sodium bisulfite (MSB)] suppresses PC progression in mice, killing cells through an oxidative cell death: MSB antagonizes the essential class III phosphatidylinositol (PI) 3-kinase VPS34-the regulator of endosome identity and sorting-through oxidation of key cysteines, pointing to a redox checkpoint in sorting. Testing MSB in a myotubular myopathy model that is driven by loss of &lt;i>MTM1&lt;/i>-the phosphatase antagonist of VPS34-we show that dietary MSB improved muscle histology and function and extended life span. These findings enhance our understanding of pro-oxidant sel</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-06-02T04:17:38.136Z</modification><creation>2025-07-05T03:04:47.268Z</creation></dates><accession>S-EPMC11975464</accession><cross_references><pubmed>39446948</pubmed><doi>10.1126/science.adk9167</doi></cross_references></HashMap>